Compelling Results Demonstrating Effectiveness of Possis' AngioJet(R) Treatment Presented at TCT (Business Wire via Yahoo! Finance)
MINNEAPOLIS----Possis Medical, Inc. announced that Dr. Georgios Sianos of the Thoraxcentre in Rotterdam, the Netherlands, today presented compelling results showing the clinical value of AngioJet treatment for coronary arterial thrombus in heart attack patients at the 2006 Transcatheter Cardiovascular Therapeutics conference in Washington, D.C.

Schering-Plough Announces FDA Approval of NOXAFIL(R) (Posaconazole) for Treatment of Oropharyngeal Candidiasis (OPC) (PR Newswire via Yahoo! Finance)
Schering-Plough Corporation today reported that the U.S. Food and Drug Administration has approved NOXAFIL Oral Suspension for the treatment of oropharyngeal candidiasis , including infections refractory to itraconazole and/or fluconazole.